Insider · CIK 0001189020

SOON-SHIONG PATRICK

Reports to the SEC for 13 companies · PRINCETON, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001189020

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-03-31	IBRXImmunityBio, Inc.C Conversion	Director, See remarks, 10% Owner	CConversion	+4.61M sh	$5.43	+$25M	251,018,873
2026-03-31	IBRXImmunityBio, Inc. · Second Amended and Restated Convertible Promissory NoteC Conversion	Director, See remarks, 10% Owner	CConversion	—	—	—	—
2026-02-22	IBRXImmunityBio, Inc.M Exercise/Conversion	Director, See remarks, 10% Owner	MExercise/Conversion	+114K sh	—	—	29,816,081
2026-02-22	IBRXImmunityBio, Inc.F Tax Payment	Director, See remarks, 10% Owner	FTax Payment	−58.2K sh	$8.70	−$506K	29,757,911
2026-02-22	IBRXImmunityBio, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, See remarks, 10% Owner	MExercise/Conversion	−114K sh	—	—	114,329
2026-02-10	IBRXImmunityBio, Inc.M Exercise/Conversion	Director, See remarks, 10% Owner	MExercise/Conversion	+274K sh	—	—	29,820,312
2026-02-10	IBRXImmunityBio, Inc.F Tax Payment	Director, See remarks, 10% Owner	FTax Payment	−119K sh	$6.93	−$822K	29,701,752
2026-02-10	IBRXImmunityBio, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, See remarks, 10% Owner	MExercise/Conversion	−274K sh	—	—	548,246
2025-02-22	IBRXImmunityBio, Inc.M Exercise/Conversion	Director, See remarks, 10% Owner	MExercise/Conversion	+114K sh	—	—	29,588,261
2025-02-22	IBRXImmunityBio, Inc.F Tax Payment	Director, See remarks, 10% Owner	FTax Payment	−42.1K sh	$3.42	−$144K	29,546,190
2025-02-22	IBRXImmunityBio, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, See remarks, 10% Owner	MExercise/Conversion	−114K sh	—	—	228,658
2025-02-10	IBRXImmunityBio, Inc. · Restricted Stock UnitsA Award	Director, See remarks, 10% Owner	AAward	+822K sh	—	—	822,368
2025-02-10	IBRXImmunityBio, Inc. · Stock Option (right to buy)A Award	Director, See remarks, 10% Owner	AAward	+2.81M sh	—	—	2,812,500
2024-12-10	IBRXImmunityBio, Inc.C Conversion	Director, See remarks, 10% Owner	CConversion	+104M sh	$1.94	+$201M	232,937,105
2024-12-10	IBRXImmunityBio, Inc.C Conversion	Director, See remarks, 10% Owner	CConversion	+13.5M sh	$2.28	+$30.7M	246,412,277
2024-12-10	IBRXImmunityBio, Inc. · Convertible Promissory NoteC Conversion	Director, See remarks, 10% Owner	CConversion	—	—	—	—
2024-12-10	IBRXImmunityBio, Inc. · Convertible Promissory NoteC Conversion	Director, See remarks, 10% Owner	CConversion	—	—	—	—
2024-12-10	IBRXImmunityBio, Inc. · Amended and Restated Promissory NoteJ Other	Director, See remarks, 10% Owner	JOther	—	—	—	—
2024-12-10	IBRXImmunityBio, Inc. · Second Amended and Restated Convertible Promissory NoteJ Other	Director, See remarks, 10% Owner	JOther	—	$505000000.00	—	—
2024-02-22	IBRXImmunityBio, Inc. · Restricted Stock UnitsA Award	Director, See remarks, 10% Owner	AAward	+343K sh	—	—	342,987
2024-02-22	IBRXImmunityBio, Inc. · Stock Option (right to buy)A Award	Director, See remarks, 10% Owner	AAward	+1.19M sh	—	—	1,193,597
2023-12-29	IBRXImmunityBio, Inc. · Amended and Restated Promissory NoteJ Other	Director, See remarks, 10% Owner	JOther	—	$380000000.00	—	—
2023-12-29	IBRXImmunityBio, Inc. · Convertible Promissory NoteJ Other	Director, See remarks, 10% Owner	JOther	—	$30000000.00	—	—
2023-09-11	IBRXImmunityBio, Inc.J Other	Director, See remarks, 10% Owner	JOther	+129M sh	$1.29	+$167M	129,227,017
2023-09-11	IBRXImmunityBio, Inc.J Other	Director, See remarks, 10% Owner	JOther	+47.6M sh	$1.29	+$61.3M	47,557,934
2023-09-11	IBRXImmunityBio, Inc.J Other	Director, See remarks, 10% Owner	JOther	+32.6M sh	$1.29	+$42.1M	32,606,985
2023-09-11	IBRXImmunityBio, Inc. · Amended and Restated Convertible Promissory NoteJ Other	Director, See remarks, 10% Owner	JOther	—	—	—	—
2023-09-11	IBRXImmunityBio, Inc. · Amended and Restated Convertible Promissory NoteJ Other	Director, See remarks, 10% Owner	JOther	—	—	—	—
2023-09-11	IBRXImmunityBio, Inc. · Second Amended and Restated Convertible Promissory NoteJ Other	Director, See remarks, 10% Owner	JOther	—	—	—	—
2023-09-11	IBRXImmunityBio, Inc. · Second Amended and Restated Convertible Promissory NoteJ Other	Director, See remarks, 10% Owner	JOther	—	—	—	—
2023-09-11	IBRXImmunityBio, Inc. · Second Amended and Restated Convertible Promissory NoteJ Other	Director, See remarks, 10% Owner	JOther	—	—	—	—
2023-09-11	IBRXImmunityBio, Inc. · Convertible Promissory NoteP Purchase	Director, See remarks, 10% Owner	PPurchase	—	$200000000.00	—	—
2023-08-28	NantHealth, Inc.P Purchase	Director, Chief Executive Officer, 10% Owner	PPurchase	+15.4M sh	$0.39	+$6M	15,384,616
2023-08-28	NantHealth, Inc.P Purchase	Director, Chief Executive Officer, 10% Owner	PPurchase	+537K sh	$18.61	+$10M	15,921,888
2023-05-12	IBRXImmunityBio, Inc. · Convertible Promissory NoteP Purchase	Director, See remarks, 10% Owner	PPurchase	—	$30445859.00	—	—
2022-12-12	IBRXImmunityBio, Inc.C Conversion	Director, See remarks, 10% Owner	CConversion	+9.99M sh	$5.67	+$56.6M	9,986,920
2022-12-12	IBRXImmunityBio, Inc. · Second Amended and Restated Convertible Promissory NoteC Conversion	Director, See remarks, 10% Owner	CConversion	—	—	—	—
2022-08-31	IBRXImmunityBio, Inc. · Amended and Restated Convertible Promissory NoteP Purchase	Director, See remarks, 10% Owner	PPurchase	—	$40407671.00	—	—
2022-08-31	IBRXImmunityBio, Inc. · Amended and Restated Convertible Promissory NoteP Purchase	Director, See remarks, 10% Owner	PPurchase	—	$55927342.00	—	—
2022-08-31	IBRXImmunityBio, Inc. · Second Amended and Restated Convertible Promissory NoteP Purchase	Director, See remarks, 10% Owner	PPurchase	—	$63375911.00	—	—
2022-08-31	IBRXImmunityBio, Inc. · Second Amended and Restated Convertible Promissory NoteP Purchase	Director, See remarks, 10% Owner	PPurchase	—	$55844638.00	—	—
2022-08-31	IBRXImmunityBio, Inc. · Second Amended and Restated Convertible Promissory NoteP Purchase	Director, See remarks, 10% Owner	PPurchase	—	$59524425.00	—	—
2022-08-31	IBRXImmunityBio, Inc. · Second Amended and Restated Convertible Promissory NoteP Purchase	Director, See remarks, 10% Owner	PPurchase	—	$40016261.00	—	—
2022-03-23	IBRXImmunityBio, Inc. · Stock Option (right to buy)A Award	Director, See remarks, 10% Owner	AAward	+350K sh	—	—	350,000
2022-03-23	IBRXImmunityBio, Inc. · Stock Option (right to buy)A Award	Director, See remarks, 10% Owner	AAward	+350K sh	—	—	350,000
2021-09-09	NantHealth, Inc.Stock Option (right to buy)A Award	Director, Chief Executive Officer, 10% Owner	AAward	+1M sh	—	—	1,000,000
2021-06-10	IBRXImmunityBio, Inc. · Stock Option (right to buy)A Award	Director, See remarks, 10% Owner	AAward	+26.1K sh	—	—	26,064
2021-04-27	NantHealth, Inc.4.50% Convertible Senior Notes due 2026P Purchase	Director, Chief Executive Officer, 10% Owner	PPurchase	+62.5M sh	$62500000.00	+$3910T	—
2021-04-13	NantHealth, Inc.P Purchase	Director, Chief Executive Officer, 10% Owner	PPurchase	+1.69M sh	$2.96	+$5M	1,689,189
2021-04-13	NantHealth, Inc.5.50% Convertible Senior Notes due 2021J Other	Director, Chief Executive Officer, 10% Owner	JOther	−5M sh	$5000000.00	−$25T	5,000,000

Recent filings

Accepted (ET)
Apr 24
SOON-SHIONG PATRICK0001189020-26-000008
SEC(opens sec.gov)
Feb 244
SOON-SHIONG PATRICK0001189020-26-000006
SEC(opens sec.gov)
Feb 124
SOON-SHIONG PATRICK0001189020-26-000003
SEC(opens sec.gov)
Feb 254
SOON-SHIONG PATRICK0001326110-25-000023
SEC(opens sec.gov)
Feb 124
SOON-SHIONG PATRICK0001326110-25-000014
SEC(opens sec.gov)
Dec 124
SOON-SHIONG PATRICK0001326110-24-000117
SEC(opens sec.gov)
Feb 264
SOON-SHIONG PATRICK0001326110-24-000024
SEC(opens sec.gov)

Companies

Address

C/O PDS BIOTECHNOLOGY CORPORATION 303A COLLEGE ROAD EAST

PRINCETON, NJ, 08540